The Role of Pharmacovigilance Within the Ongoing Coronavirus Pandemic
As the coronavirus pandemic continues, the roles and responsibilities of pharmacovigilance professionals become evermore important. Assessing the efficacy and safety of treatments has been paramount to in helping countries around the world slowly take control of the situation. At present, The European Medicines Agency's Pharmacovigilance Risk Assessment Committee (PRAC) is assessing the risk of multisystem inflammatory syndrome (MIS) and the German Pfizer BioNTech vaccine, after a case in Denmark.
View full press release